ロード中...
The changing landscape in the treatment of metastatic castration-resistant prostate cancer
The past few years have brought increasing advances in the therapeutic management of metastatic castration-resistant prostate cancer with the approval of several agents, including vaccine therapy with sipuleucel-T, second-line chemotherapy with cabazitaxel, the bone-targeted pharmaceutical denosumab...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539272/ https://ncbi.nlm.nih.gov/pubmed/23323145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012458137 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|